$0.00
(+0.00%
) Quote details
USD
( +0.00%
At Close (As of Jan 1, 1970)
$2.09B
Market Cap
28.36
P/E Ratio
0.56
EPS
$16.48
52 Week High
$6.55
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Aurinia Pharmaceuticals Inc. (AUPH) is a biopharmaceutical company dedicated to developing innovative therapies for serious diseases, with a primary focus on lupus nephritis. Based in Victoria, Canada, the company utilizes its extensive drug development expertise to create and deliver impactful treatment solutions, targeting critical healthcare needs in major markets including Japan and China. Aurinia's commitment to enhancing patient outcomes positions it strategically in the evolving biopharmaceutical sector, with ongoing potential for growth as it addresses significant unmet medical needs.
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
WULF
MARA
PLTR
VALE
BAC
RR
APLT
SNAP
CLSK
BITF
DNN
IREN
IVP
PFE
BYND
IRBT
GOOGL
QBTS
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
SMR
MTSR
FI
WBD
HOOD
HL
JBLU
APLD
CAN
SOUN
CDE
T
AG
BTBT
DVLT
NOK
EOSE
GOOG
LUV
ASTS
LPTX
NVDA
CGC
WOK
PLUG
ASST
TSLA
AVGO
INTC
TLRY
KIND
IQ
TNYA
KAVL
ORCL
SOFI
ADAP
F
PLTD
AAL
HPE
KVUE
WULF
MARA
PLTR
VALE
BAC
RR
APLT
SNAP
CLSK
BITF
DNN
IREN
IVP
PFE
BYND
IRBT
GOOGL
QBTS
NIO
CIFR
NFLX
ASBP
AMD
RKLB
GRAB
SMR
MTSR
FI
WBD
HOOD
HL
JBLU
APLD
CAN
SOUN
CDE
T
AG
BTBT
DVLT
NOK
EOSE
GOOG
LUV
ASTS